Equities

Youcare Pharmaceutical Group Co Ltd

688658:SHH

Youcare Pharmaceutical Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)16.55
  • Today's Change0.93 / 5.95%
  • Shares traded3.08m
  • 1 Year change-2.30%
  • Beta1.2304
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,3741,5182,291
Total Receivables, Net1,1431,406966
Total Inventory728738632
Prepaid expenses7310031
Other current assets, total108139145
Total current assets3,4253,9014,066
Property, plant & equipment, net1,9991,7141,369
Goodwill, net------
Intangibles, net435369277
Long term investments16----
Note receivable - long term------
Other long term assets------
Total assets5,9116,0085,727
LIABILITIES
Accounts payable506497512
Accrued expenses110115129
Notes payable/short-term debt567509297
Current portion long-term debt/capital leases10----
Other current liabilities, total943778745
Total current liabilities2,1371,8991,682
Total long term debt844024
Total debt661549321
Deferred income tax------
Minority interest9.808.093.38
Other liabilities, total937294
Total liabilities2,3232,0191,803
SHAREHOLDERS EQUITY
Common stock450450450
Additional paid-in capital2,6452,6812,645
Retained earnings (accumulated deficit)548858829
Treasury stock - common(55)----
Unrealized gain (loss)------
Other equity, total------
Total equity3,5883,9893,924
Total liabilities & shareholders' equity5,9116,0085,727
Total common shares outstanding447450450
Treasury shares - common primary issue2.8200
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.